Cargando…

The Cost of Annual versus Biannual Community-Directed Treatment of Onchocerciasis with Ivermectin: Ghana as a Case Study

BACKGROUND: It has been proposed that switching from annual to biannual (twice yearly) mass community-directed treatment with ivermectin (CDTI) might improve the chances of onchocerciasis elimination in some African foci. However, historically, relatively few communities have received biannual treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turner, Hugo C., Osei-Atweneboana, Mike Y., Walker, Martin, Tettevi, Edward J., Churcher, Thomas S., Asiedu, Odame, Biritwum, Nana-Kwadwo, Basáñez, María-Gloria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777881/ https://www.ncbi.nlm.nih.gov/pubmed/24069497 http://dx.doi.org/10.1371/journal.pntd.0002452

Ejemplares similares

Reaching the London Declaration on Neglected Tropical Diseases Goals for Onchocerciasis: An Economic Evaluation of Increasing the Frequency of Ivermectin Treatment in Africa
por: Turner, Hugo C., et al.
Publicado: (2014)

Uncertainty Surrounding Projections of the Long-Term Impact of Ivermectin Treatment on Human Onchocerciasis
por: Turner, Hugo C., et al.
Publicado: (2013)

Onchocerciasis control in Ghana (1974–2016)
por: Biritwum, Nana-Kwadwo, et al.
Publicado: (2021)

Onchocerciasis Transmission in Ghana: Persistence under Different Control Strategies and the Role of the Simuliid Vectors
por: Lamberton, Poppy H. L., et al.
Publicado: (2015)

Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana
por: Minetti, Corrado, et al.
Publicado: (2019)

Does Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness?
por: Frempong, Kwadwo K., et al.
Publicado: (2016)

Onchocerciasis Control: Vision for the Future from a Ghanian perspective
por: Taylor, Mark J, et al.
Publicado: (2009)

Onchocerciasis transmission in Ghana: biting and parous rates of host-seeking sibling species of the Simulium damnosum complex
por: Lamberton, Poppy HL, et al.
Publicado: (2014)

Onchocerciasis transmission in Ghana: the human blood index of sibling species of the Simulium damnosum complex
por: Lamberton, Poppy H. L., et al.
Publicado: (2016)

Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections
por: Turner, Hugo C, et al.
Publicado: (2014)

Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial
por: de Souza, Dziedzom K., et al.
Publicado: (2017)

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
por: Stolk, Wilma A., et al.
Publicado: (2015)

Demographic patterns of human antibody levels to Simulium damnosum s.l. saliva in onchocerciasis-endemic areas: An indicator of exposure to vector bites
por: Willen, Laura, et al.
Publicado: (2022)

Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
por: Brieger, William R, et al.
Publicado: (2011)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
por: Otabil, Kenneth Bentum, et al.
Publicado: (2023)

Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
por: Otabil, Kenneth Bentum, et al.
Publicado: (2023)

Scaling-Down Mass Ivermectin Treatment for Onchocerciasis Elimination: Modeling the Impact of the Geographical Unit for Decision Making
por: Stolk, Wilma A, et al.
Publicado: (2021)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin
por: Wilson, Nana O., et al.
Publicado: (2016)

Sustainable Control of Onchocerciasis: Ocular Pathology in Onchocerciasis Patients Treated Annually with Ivermectin for 23 Years: A Cohort Study
por: Banla, Méba, et al.
Publicado: (2014)

Onchocerciasis transmission status in some endemic communities of Cross River State, Nigeria after two decades of mass drug administration with ivermectin
por: Chikezie, Friday Maduka, et al.
Publicado: (2023)

Potential effects of warmer worms and vectors on onchocerciasis transmission in West Africa
por: Cheke, Robert A., et al.
Publicado: (2015)

Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme
por: Turner, Hugo C., et al.
Publicado: (2015)

Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2018)

Human immune response against salivary antigens of Simulium damnosum s.l.: A new epidemiological marker for exposure to blackfly bites in onchocerciasis endemic areas
por: Willen, Laura, et al.
Publicado: (2021)

Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial
por: Batsa Debrah, Linda, et al.
Publicado: (2020)

Economic evaluations of onchocerciasis interventions: a systematic review and research needs
por: Turner, Hugo C., et al.
Publicado: (2019)

Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon
por: Forrer, Armelle, et al.
Publicado: (2021)

Fifteen Years of Annual Mass Treatment of Onchocerciasis with Ivermectin Have Not Interrupted Transmission in the West Region of Cameroon
por: Katabarwa, Moses N., et al.
Publicado: (2013)

How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control
por: Verver, Suzanne, et al.
Publicado: (2018)

Compliance to a Five-Year Biannual Ivermectin Treatment for Onchocerciasis Elimination and Its Determinants among Adults in the Bench Maji Zone, Southwest Ethiopia: A Community-Based Cross-Sectional Study
por: Kifle, Bedilu, et al.
Publicado: (2021)

A Review of African Medicinal Plants and Functional Foods for the Management of Alzheimer's Disease-related Phenotypes, Treatment of HSV-1 Infection and/or Improvement of Gut Microbiota
por: Tettevi, Edward Jenner, et al.
Publicado: (2022)

Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases
por: Twum-Danso, Nana AY
Publicado: (2003)

Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin
por: Otabil, Kenneth Bentum, et al.
Publicado: (2019)

Associations of IL13 gene polymorphisms and immune factors with Schistosoma haematobium infection in schoolchildren in four schistosomiasis-endemic communities in Ghana
por: Sarpong-Baidoo, Margaret, et al.
Publicado: (2021)

Phenotypic Evidence of Emerging Ivermectin Resistance in Onchocerca volvulus
por: Osei-Atweneboana, Mike Y., et al.
Publicado: (2011)

The COUNTDOWN Study Protocol for Expansion of Mass Drug Administration Strategies against Schistosomiasis and Soil-Transmitted Helminthiasis in Ghana
por: Campbell, Suzy J., et al.
Publicado: (2018)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso
por: Nikièma, Achille S., et al.
Publicado: (2021)

Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities
por: Biritwum, Nana Kwadwo, et al.
Publicado: (2019)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
por: Siewe Fodjo, Joseph Nelson, et al.
Publicado: (2019)

The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data
por: Turner, Hugo C, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bq3uqksst3rbrlad2do41sbrnt